Patent Assignment
Reel/Frame 022566/0174
Assignment of Assignor's Interest
Recorded: 2009-04-20
Received: 2009-04-20
Pages: 5
Assignor
NOVO NORDISK A/S
Executed: 2009-03-16
Assignee
TRANSTECH PHARMA, INC.
4170 MENDENHALL OAKS PARKWAY, HIGH POINT, NC, 27265, UNITED STATES
Covered Properties
(14)
11BETA-Hydroxysteroid Dehydrogenase Type 1 Active Spiro Compounds
Application:
11/665,103 →
Pharmaceutical Use of Substituted Amides
Application:
12/092,230 →
Pharmaceutical Use of Substituted Amides
Application:
12/092,223 →
Pharmaceutical Use of Fused 1,2,4-Triazoles
Application:
12/038,255 →
Pharmaceutical use of substituted amides
Application:
12/006,765 →
Pharmaceutical use of substituted amides
Application:
60/926,924 →
Novel compounds
Application:
60/923,251 →
11Beta-HSD1 active compounds
Application:
60/920,433 →
Combination Therapy Using an 11BETA-Hydroxysteroid Dehydrogenase Type 1 Inhibitor and an Antihypertensive Agent for the Treatment of Metabolic Syndrome and Related Diseases and Disorders
Application:
11/254,125 →
Pharmaceutical use of substituted amides
Application:
11/265,794 →
Pharmaceutical Use of Fused 1,2,4-Triazoles
Application:
11/247,847 →
Pharmaceutical Use of Substituted Pyrazolo[1,5-A]Pyrimidines
Application:
11/254,118 →
Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy
Application:
11/246,814 →
11BETA-Hydroxysteroid Dehydrogenase Type 1 Active Compounds
Application:
11/244,745 →